Hepatitis B surface antigen declines and clearance during long-term tenofovir therapy in patients coinfected with HBV and HIV.

MLA

Zoutendijk, Roeland, et al. “Hepatitis B Surface Antigen Declines and Clearance during Long-Term Tenofovir Therapy in Patients Coinfected with HBV and HIV.” The Journal of Infectious Diseases, vol. 206, no. 6, Sept. 2012, pp. 974–80. EBSCOhost, https://doi.org/10.1093/infdis/jis439.

APA

Zoutendijk, R., Zaaijer, H. L., de Vries-Sluijs, T. E. M. S., Reijnders, J. G. P., Mulder, J. W., Kroon, F. P., Richter, C., van der Eijk, A. A., Sonneveld, M. J., Hansen, B. E., de Man, R. A., van der Ende, M. E., & Janssen, H. L. A. (2012). Hepatitis B surface antigen declines and clearance during long-term tenofovir therapy in patients coinfected with HBV and HIV. The Journal of Infectious Diseases, 206(6), 974–980. https://doi.org/10.1093/infdis/jis439

Chicago

Zoutendijk, Roeland, Hans L Zaaijer, Theodora E M S de Vries-Sluijs, Jurrien G P Reijnders, Jan W Mulder, Frank P Kroon, Clemens Richter, et al. 2012. “Hepatitis B Surface Antigen Declines and Clearance during Long-Term Tenofovir Therapy in Patients Coinfected with HBV and HIV.” The Journal of Infectious Diseases 206 (6): 974–80. doi:10.1093/infdis/jis439.